Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.
NCT05817227 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2025-12-22
Summary
This is multicentric, spontaneous, observational, retrospective and prospective study.
Conditions
Sponsors & Collaborators
-
National Cancer Institute, Naples
lead OTHER
Principal Investigators
-
Alfredo Budillon, M.D. · IRCCS I.N.T. "G. Pascale"
-
Susan Costantini, PhD · IRCCS I.N.T. "G. Pascale"
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-05-19
- Primary Completion
- 2027-11-19
- Completion
- 2027-11-19
Countries
- Italy
Study Locations
More Related Trials
-
InheriteD brEast caNcer iTalian regIsTrY A Retrospective-prospective Observational Cohort Study to Evaluate Cancer Prevention Strategies in Women With a Deleterious Mutation in BRCA1-2
NCT05835739 ·Status: RECRUITING
-
Genetic and Protein Profiling in Normal and Cancerous Breast Tissue
NCT00083733 ·Status: COMPLETED
-
Molecular Signature for Breast Cancer
NCT05724407 ·Status: UNKNOWN
-
Prospective Evaluation of Breast Cancer at Brazilian Institutions - Project AMAZONA III
NCT02663973 ·Status: COMPLETED
-
S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and Fluorouracil
NCT00897091 ·Status: COMPLETED
-
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast Cancer
NCT03255577 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of Prognostic Monitoring for Triple Negative Breast Cancer Patients
NCT04145947 ·Status: UNKNOWN
-
Study of Tumor and Blood Samples From Women With Breast Cancer
NCT00897728 ·Status: UNKNOWN
-
Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17
NCT00897065 ·Status: UNKNOWN
-
RNA and Heat Shock Protein Biomarkers in Radiation-induced Fibrosis in Breast Cancer
NCT03000764 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Breast Cancer
NCT04145960 ·Status: UNKNOWN
-
Locoregional Recurrence of Breast Cancer
NCT05988112 ·Status: NOT_YET_RECRUITING
-
Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
NCT01000883 ·Status: RECRUITING
-
Exploring the Role of Serum Methylmalonic Acid (MMA) in Breast Cancer
NCT05352737 ·Status: COMPLETED
-
Prospective Observational Study for Breast Microcalcifications' Classification With Artificial Intelligence Techniques
NCT05767424 ·Status: ACTIVE_NOT_RECRUITING
-
Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer
NCT01514565 ·Status: UNKNOWN
-
Monitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulating ESR1 DNA
NCT05814224 ·Status: UNKNOWN ·Phase: NA
-
A Study of ZN-c5 in Participants With Breast Cancer
NCT04176757 ·Status: COMPLETED ·Phase: PHASE1
-
Identification of Genes That Predict Local Recurrence in Samples From Patients With Breast Cancer Treated on NSABP-B-28
NCT01420185 ·Status: UNKNOWN
-
Prognostic Value of Stem Cell Related Markers
NCT01265225 ·Status: WITHDRAWN
-
Identification of Breast Cancer Specific Markers in Patients Compared to Healthy Participants
NCT05054010 ·Status: ACTIVE_NOT_RECRUITING
-
BRCA and NACT in TNBC Patients
NCT05750719 ·Status: COMPLETED
-
Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and Serum
NCT01042548 ·Status: RECRUITING
-
Using Bio Markers to Predict Disease Recurrence and Cognitive Function in High Risk Breast Ca
NCT00756132 ·Status: COMPLETED
-
Identification of Biomarkers in Women at High Risk or Average Risk of Breast Cancer
NCT00897416 ·Status: COMPLETED